In particular, Aurora kinase A (AURKA) expression is 7.9-fold higher in human and murine MPNST samples than in healthy, and its pharmacological inhibition reduces tumor cell survival in vitro and in vivo [23]. Here, AURKA is linked to malignant peripheral nerve sheath tumor.